Physician profile
Scott K Watson
NPI 1144419037
$1,339.91
in general payments reported to CMS, 2019-2025
16 companies · $228 in 2025
The $228 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $42.86 · 2022: $267 · 2023: $160 · 2024: $363 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $298.25 | 2022-2024 | Azstarys |
| Sobi, INC | $194.44 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $178.23 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $165.80 | 2022-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $86.23 | 2025 | Jornay Pm |
| Pfizer INC. | $85.72 | 2022-2025 | |
| Shire North American Group INC | $76.30 | 2019 | |
| Merck Sharp & Dohme LLC | $68.77 | 2020-2024 | Vaxelis, Gardasil 9, Gardasil |
| Cranial Technologies, INC | $44.01 | 2020-2025 | Doc Band |
| Alk-Abello, INC | $34.65 | 2025 | Neffy |
| Ars Pharmaceuticals Operations, INC. | $24.82 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $19.47 | 2019 | |
| Neos Therapeutics, LP | $17.14 | 2019 | |
| Tris Pharma INC | $15.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.34 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $15.18 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.